-
Security Type
-
SAFE
-
Min Investment
-
$100
-
Offering Date
-
December 10, 2020
-
Expected Close Date
-
April 30, 2021
-
Target Raise
-
$50.00K-$1.07M
-
Deal Notes
-
Price Per Share: $1.00
Company Description
Curo46 uses Artificial Intelligence and our algorithm to take a holistic approach to your health. We collect data from all areas: medical history, genetic markers, consumption habits, health trackers, and more.
Key Deal Facts
Diseases and treatments affect everyone differently.
Underlying relationships are too complex to be understood by today’s health and medical industries.
Curo46’s AI revolutionizes our understanding of an individual’s health risks.
Our interface gives people control over their health/medical history and who gets access to it.
Our applications are fully protected and supported with patents.
Proven technical and commercial expertise to successfully develop, and deploy our products.
Existing contracts with the government, military, education institutions, and countless companies.
Stonebridge Advisory Inc. rendered a current fair market value estimated at $320,000,000.
Use of Proceeds
$50,000
- We will able to add 2 full-time staff members and the amount will be distributed to cover the company's implementation strategy based on the outlined breakdown below: Marketing & Customer Acquisition 35%; will cover advertising & promotions, selling expenses (e.g. travel, commissions), events & conferences, marketing team salaries (digital marketing manager, sales team and employees benefit costs. Operations & Salaries 35%; will cover bank charges, office rent, electricity, travel allowance, finance, operations, legal charges, insurance professional fees, salaries. Information Technology 12.5%; Infrastructure, internet, wireless, telephony, software, salaries. Research & Development 10%; Additional IP development, patent filings, technology scaling. Wefunder fee 7.5%.
$1,070,000
- We will able to add 7 full-time staff members and the amount will be distributed to cover the company's implementation strategy based on the outlined breakdown below: Marketing & Customer Acquisition 50%; will cover advertising & promotions, selling expenses (e.g. travel, commissions), events & conferences, marketing team salaries (account manager, digital marketing manager, marketing assistants, retail sales agent, sales team and employees benefit costs. Operations & Salaries 20%; will cover bank charges, office rent, electricity, travel allowance, finance, operations, legal charges, insurance professional fees, salaries (CEO, CFO, CTO, bookkeeper, accountant, hr manager, employee benefit cost). Information Technology 12.5%; Infrastructure, internet, wireless, telephony, software, salaries. Research & Development 10%; Additional IP development, patent filings, technology scaling. Wefunder fee 7.5%
Management Team / Advisory Board Bios
AJ Rosenthal, President
AJ Rosenthal’s career has spanned data science and sales. After serving eight plus years as a US Navy nuclear engineer, AJ built a career in the energy industry. His deep expertise has helped General Genomics secure 3 patents and apply for 20+ more.
Warren Dennis Gieck, SVP, Engineering & Product Development
With deep experience in AI development and market launch, Warren has led AI-driven digital transformations at global leaders GE and Baker Hughes. Additionally, he's built critical robotics and industrial automation programs, including GE’s Adaptix.
Caleb Stuart, SVP, General Counsel, and Secretary
Caleb brings business law and contracts expertise to General Genomics. After serving four years in the US Marine Corps and earning a JD, Caleb built the Stuart Firm, a practice focused on commercial litigation in the energy and construction industry.